Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of an SSX-2 epitope presented by dendritic cells to circulating autologous CD4+ T cells.

Journal of immunology (Baltimore, Md. : 1950) - 1 Jun 2004

Ayyoub Maha, Hesdorffer Charles S, Metthez Genevieve, Stevanovic Stefan, Ritter Gerd, Chen Yao-Tseng, Old Lloyd J, Speiser Daniel, Cerottini Jean-Charles, Valmori Danila

Abstract excerpt

Accumulating evidence supports the requirement for both tumor-specific CD8(+) and CD4(+) T cell responses for efficient tumor rejection to occur. Because of its expression in different tumor types, the cancer/testis Ag encoded by the synovial sarcoma X breakpoint 2 (SSX-2) gene is among the most relevant candidates for the development of generic cancer vaccines. The immunogenicity of SSX-2 has been previously...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigen Presentation
Share to Antigen-Presenting Cells

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to CD4-Positive T-Lymphocytes

Share to Dendritic Cells

Share to Epitope Mapping

Share to Epitopes, T-Lymphocyte

Share to HLA-DP Antigens

Share to Peptide Fragments

Source

Identifiers

PMID: 15153546
DOI: 10.4049/jimmunol.172.11.7206

Genes

APC

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of an SSX-2 epitope presented by dendritic cells to circulating autologous CD4+ T cells.PMID 15153546Read ↗

CD4+ T cell responses to SSX-4 in melanoma patients.Semantic proximity Read ↗

Distinct but overlapping T helper epitopes in the 37-58 region of SSX-2.Semantic proximity Read ↗

Identification of NY-ESO-1 epitopes presented by human histocompatibility antigen (HLA)-DRB4*0101-0103 and recognized by CD4(+) T lymphocytes of patients with NY-ESO-1-expressing melanoma.Semantic proximity Read ↗

Dendritic Cells Loaded With mRNA Encoding Full-length Tumor Antigens Prime CD4+ and CD8+ T Cells in Melanoma PatientsSemantic proximity Read ↗

Distinct sets of αβ TCRs confer similar recognition of tumor antigen NY-ESO-1 <sub>157–165</sub> by interacting with its central Met/Trp residuesSemantic proximity Read ↗

Case Report: Targeting of individual somatic tumor mutations by multipeptide vaccination tailored for HLA class I and II presentation induces strong CD4 and CD8 T-cell responses in a patient with metastatic castration sensitive prostate cancer.Semantic proximity Read ↗

DSG2-Directed CAR-T Cells Safely and Universally Eliminate Solid TumorsSemantic proximity Read ↗

Melanoma antigens recognised by CD8+ and CD4+ T cells.Semantic proximity Read ↗

CD4(+) T cell recognition of MHC class II-restricted epitopes from NY-ESO-1 presented by a prevalent HLA DP4 allele: association with NY-ESO-1 antibody production.Semantic proximity Read ↗

Identification of HLA‐A2‐ and A24‐restricted T‐cell epitopes derived from SOX6 expressed in glioma stem cells for immunotherapySemantic proximity Read ↗

HLA-B35-restricted immune responses against survivin in cancer patients.Semantic proximity Read ↗

Immunogenicity without immunoselection: a mutant but functional antioxidant enzyme retained in a human metastatic melanoma and targeted by CD8(+) T cells with a memory phenotype.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.